#USA #Veeva Systems #Clinical Trials #Pleasanton #eSource

Veeva eSource: A Leap Towards Efficient Clinical Trials

Veeva Systems has recently announced the launch of its innovative application, Veeva eSource, aimed at transforming the landscape of clinical trials. With a focus on eliminating paper-based processes, this new application integrates electronic health records (EHR) with electronic data capture (EDC) systems to enhance the efficiency and quality of clinical study data collection.

Reducing Manual Processes

According to Alisha Garibaldi, CEO of Skylight Health Research, the programming and data transfer involved in traditional eSource solutions can be exceedingly time-consuming. Veeva eSource introduces a more streamlined approach, allowing clinical sites to capture study data digitally, significantly reducing manual input and potential errors. This is a significant step forward in ensuring that staff can dedicate more time to patient care rather than administrative tasks.

Key Features of Veeva eSource

1. EHR Integration—A Game Changer

Veeva eSource facilitates the transfer of relevant patient data directly from EHR systems into the eSource application, and onwards to EDC systems. This integration substantially diminishes the burden of double data entry that is common in traditional settings, ultimately relieving both sites and patients of unnecessary administrative tasks.

2. Direct Data Capture

The eSource application provides a user-friendly platform for sites to record study data in a digital format, moving away from cumbersome paper-based methods. This not only enhances the patient experience but also aligns with the Veeva SiteVault CTMS to ensure a cohesive journey throughout the clinical study.

3. Automated EDC Integration

With the flow of patient data from eSource to Veeva EDC automated, the latency and risk of errors typically associated with data transfer processes are significantly reduced. Moreover, Veeva’s open API allows for easy connections to various EDC systems, enhancing flexibility for study sites.

4. Elimination of Source Data Verification (SDV)

By utilizing source data directly instead of transcribing it later, Veeva eSource negates the lengthy and often tedious SDV processes needed by sponsors. This change allows sponsor staff to focus more on direct interactions with sites and patients, optimizing the entire clinical trial experience.

A Vision for the Future

Jim Reilly, President of Veeva Development Cloud, expressed, "For the first time, we are connecting data and processes to enable direct clinical data flow from sites to sponsors." This statement underlines an essential shift towards greater operational efficiency and improved experiences for all stakeholders involved in clinical trials—sponsors, sites, and patients alike.

Further, Nick Frenzer, General Manager of Veeva Site Solutions, stated, "Veeva eSource brings us closer to our goal of delivering substantial efficiency and simplicity to clinical study sites." This integration of transparency across sites is set to enhance overall data management and study effectiveness.

Availability and Future Outlook

Veeva eSource is part of the Veeva SiteVault platform and is expected to be accessible to early adopters in the latter half of 2026. As Veeva continues to expand its technological capabilities within the life sciences sector, the introduction of eSource highlights their commitment to progressive innovation that prioritizes stakeholder success across the clinical research landscape.

About Veeva Systems

Veeva Systems stands out as a leading provider of cloud-based solutions for the life sciences industry, servicing over 1,500 clients that range from major biopharmaceutical firms to emerging biotech companies. With a strong focus on innovation and customer success, Veeva strives to align the interests of various stakeholders—be it customers, employees, or shareholders. To learn more, visit veeva.com.

In conclusion, Veeva eSource represents a crucial step in revolutionizing how clinical trials are conducted, ultimately contributing to faster and more efficient medical research outcomes.

• ---